DHEA-S Level of 0.581 in a 48-Year-Old Woman
A DHEA-S level of 0.581 µg/mL (58.1 µg/dL) in a 48-year-old woman is low and falls below the normal range for her age, suggesting reduced adrenal androgen production that may warrant clinical correlation with symptoms and consideration of underlying adrenal insufficiency or age-related decline.
Clinical Significance
The reported value requires careful interpretation in context:
Normal Reference Range Context
- Normal postmenopausal women demonstrate wide variability in DHEA-S levels, with mean concentrations around 2.03 ± 1.33 ng/mL (203 ± 133 µg/dL), and 5th to 95th percentiles ranging from 0.55 to 4.34 ng/mL (55-434 µg/dL) 1
- Your patient's level of 58.1 µg/dL falls at approximately the 5th percentile, indicating significantly reduced adrenal androgen production
- DHEA-S physiologically peaks between ages 20-30 years and declines gradually with age, independent of menopause 2, 1
Diagnostic Considerations
Evaluate for adrenal insufficiency if clinically indicated:
- DHEA-S <40 µg/dL has 84% specificity for autonomous cortisol secretion/adrenal dysfunction 3
- While your patient's level is just above this threshold, it remains markedly low for age
- Consider measuring morning cortisol (8-9 AM) and ACTH if symptoms suggest adrenal insufficiency (fatigue, postural hypotension, salt craving) 2
Clinical symptoms to assess:
- Low energy levels, depressive symptoms, or reduced libido (common with low DHEA-S in women) 2
- Signs of glucocorticoid or mineralocorticoid deficiency if adrenal insufficiency suspected
- Cardiovascular risk factors, as low DHEA-S associates with worse endothelial function and cardiovascular outcomes 4, 5
Management Algorithm
Step 1: Clinical Assessment
- Evaluate for symptoms: fatigue, mood changes, low libido, postural dizziness
- Check blood pressure (sitting and standing), weight, energy levels
- Review medication history (glucocorticoids, phenytoin)
Step 2: Additional Testing if Symptomatic
- Morning cortisol (8-9 AM, fasting)
- ACTH level
- Electrolytes (sodium, potassium)
- Consider dynamic testing (ACTH stimulation) if morning cortisol <10 µg/dL 6
Step 3: Treatment Consideration
If primary adrenal insufficiency confirmed:
- Glucocorticoid and mineralocorticoid replacement per standard protocols 2
- DHEA replacement (25-50 mg oral, morning dose) may be considered in women with persistent low libido, depressive symptoms, or low energy despite optimized glucocorticoid/mineralocorticoid replacement 2
DHEA replacement monitoring:
- Measure morning serum DHEA-S before daily dose, targeting mid-normal range for premenopausal women 2
- Trial period of 6 months; discontinue if no sustained benefit 2
Important Caveats
- Evidence for routine DHEA supplementation is weak: Meta-analyses show insufficient evidence for substantial clinical benefit in adrenal insufficiency 2
- DHEA replacement should only follow optimization of glucocorticoid and mineralocorticoid therapy if adrenal insufficiency present 2
- Low DHEA-S alone does not diagnose adrenal insufficiency—requires correlation with cortisol/ACTH axis evaluation 6, 3
- Some women with low DHEA-S remain asymptomatic due to individual variability in tissue sensitivity 1
Key Clinical Pitfalls
- Do not treat the number alone: Low DHEA-S without symptoms or confirmed adrenal insufficiency does not require intervention
- Age-related decline is physiologic: Many healthy postmenopausal women have low DHEA-S without clinical consequences 1
- Avoid over-supplementation: DHEA is available over-the-counter but should be medically supervised if used, with monitoring to avoid supraphysiologic levels 2